BB Biotech Update November 2022

November was a positive month for the biotech sector. The Nasdaq Biotech Index was up by 5.9% (in USD) in November, BB Biotech´s share price was up by 2.9% (in CHF) and Net Asset Value was up by 3.1% ( in USD) in the same period. This is a continuation of the positive trend in October. On a macro level, the US October consumer price index (CPI), reported in early November, rose less than expected suggesting that inflation which still remains a threat may have peaked and begun to roll over into the end of the year.